L. Pauer

1.4k citations

39 papers · 1.1k indexed · h-index 19

Impact in

Psychiatry and Mental health top 5%
- Fibromyalgia and Chronic Fatigue Syndrome Research
Pharmacology top 2%
- Musculoskeletal pain and rehabilitation

Papers in ⓘ

Psychiatry and Mental health 24
- Fibromyalgia and Chronic Fatigue Syndrome Research 24
Pharmacology 26
- Musculoskeletal pain and rehabilitation 23

Co-authors: Joseph C. Arezzo (3 shared papers)Julio Rosenstock (3 shared papers)Linda LaMoreaux (1 shared paper)Daniel J. Clauw (6 shared papers)Ed Whalen (8 shared papers)Lesley M. Arnold (10 shared papers)Richard E. Harris (4 shared papers)Vitaly Napadow (2 shared papers)
Journals: Journal of Pain (7 papers)Clinical Journal of Pain (5 papers)Pain Medicine (3 papers)European Psychiatry (3 papers)The Journal of Rheumatology (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

L. Pauer

39 papers receiving 1.0k citations

Peers

Countries citing papers authored by L. Pauer

Since Specialization

Citations

This map shows the geographic impact of L. Pauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pauer more than expected).

Fields of papers citing papers by L. Pauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pauer. The network helps show where L. Pauer may publish in the future.

Co-authors

The 25 scholars most cited alongside L. Pauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Pauer Line = papers co-authored together L. Pauer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients Anesthesiology ·Richard E. Harris, Vitaly Napadow, John P. Huggins, L. Pauer, Jieun Kim, Johnson P. Hampson, Pia C. Sundgren, Bradley R. Foerster, M.D. Ilya Petrou, Tobias Schmidt‐Wilcke, Daniel J. Clauw	2013	197
2	Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial BMC Neurology ·Joseph C. Arezzo, Julio Rosenstock, Linda LaMoreaux, L. Pauer	2008	153
3	Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors Cancer Investigation ·L. Pauer, Jairo Olivares, Casey Cunningham, A. S. Williams, William R. Grove, Alan J. Kraker, Stephen C. Olson, John Nemunaitis	2004	94
4	Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder The British Journal of Psychiatry ·Stuart Montgomery, Krai Chatamra, L. Pauer, Ed Whalen, F. Baldinetti	2008	90
5	An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia The Journal of Rheumatology ·L. Pauer, Andreas Winkelmann, Pierre Arsenault, Anders Jespersen, L. Whelan, Gary Atkinson, Teresa León, Bernhardt Zeiher	2011	70
6	Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study Pediatric Rheumatology ·(unknown), Lesley M. Arnold, Kenneth N. Schikler, Lucinda Bateman, Tahira Khan, L. Pauer, Pritha Bhadra-Brown, Andrew Clair, Marci L. Chew, Joseph M. Scavone	2016	37
7	Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study The Journal of Rheumatology ·Lesley M. Arnold, Piercarlo Sarzi‐Puttini, Pierre Arsenault, Tahira Khan, Pritha Bhadra Brown, Andrew Clair, Joseph M. Scavone, Joseph R. Driscoll, Jaren W. Landen, L. Pauer	2015	35
8	Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy Clinical Journal of Pain ·Philip Raskin, Cynthia Huffman, Cory Toth, Michael J. Asmus, Michael Messig, Robert J. Sanchez, L. Pauer	2013	30
9	Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging British Journal of Anaesthesia ·Vishvarani Wanigasekera, K Wartolowska, J.P. Huggins, Eugene Duff, W. Vennart, Mark Whitlock, Nathalie J. Massat, L. Pauer, Peter Rogers, B. Hoggart, Irene Tracey	2017	29
10	Normalizing fibromyalgia as a chronic illness Postgraduate Medicine ·Daniel J. Clauw, Yvonne D’Arcy, Kevin B. Gebke, David Semel, L. Pauer, Kim Dupree Jones	2017	27
11	An evidence-based review of pregabalin for the treatment of fibromyalgia Current Medical Research and Opinion ·Lesley M. Arnold, Ernest Choy, Daniel J. Clauw, Hiroshi Oka, Ed Whalen, David Semel, L. Pauer, Lloyd Knapp	2018	26
12	Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking Clinical Journal of Pain ·Cynthia Huffman, Brett R. Stacey, Michael Tuchman, Claire Burbridge, Chunming Li, Bruce Parsons, L. Pauer, Joseph M. Scavone, Regina Behar, Lorraine Yurkewicz	2015	24
13	Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo‐controlled trial Journal of Diabetes ·Yiming Mu, Xiao-Min Liu, Quanmin Li, Kangning Chen, Yu Liu, Xiaofeng Lv, Xiangjin Xu, Dongsheng Fan, Ningxiu Shang, Ruoyong Yang, L. Pauer, Changyu Pan	2017	24
14	Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study Current Medical Research and Opinion ·Lesley M. Arnold, Pierre Arsenault, Cynthia Huffman, Jeffrey Patrick, Michael Messig, Marci L. Chew, Luis Sanin, Joseph M. Scavone, L. Pauer, Andrew Clair	2014	23
15	Safety Profile and Tolerability of Up to 1 Year of Pregabalin Treatment in 3 Open-Label Extension Studies in Patients With Fibromyalgia Clinical Therapeutics ·Lesley M. Arnold, Birol Emir, T.K. Murphy, Bernhardt Zeiher, L. Pauer, Gayle Scott, Danielle Petersel	2012	21
16	Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions Clinical Journal of Pain ·Philip Raskin, Cynthia Huffman, Lorraine Yurkewicz, L. Pauer, Joseph M. Scavone, Ruoyong Yang, Bruce Parsons	2015	20
17	Time to Improvement of Pain and Sleep Quality in Clinical Trials of Pregabalin for the Treatment of Fibromyalgia Pain Medicine ·Lesley M. Arnold, Birol Emir, L. Pauer, Malca Resnick, Andrew Clair	2014	20
18	Association of Alterations in Gray Matter Volume With Reduced Evoked‐Pain Connectivity Following Short‐Term Administration of Pregabalin in Patients With Fibromyalgia Arthritis & Rheumatology ·Tudor Puiu, Anson Kairys, L. Pauer, Tobias Schmidt‐Wilcke, Eric Ichesco, Johnson P. Hampson, Vitaly Napadow, Daniel J. Clauw, Richard E. Harris	2016	18
19	Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study Arthritis & Rheumatology ·Eric Ichesco, Scott Peltier, Ishtiaq Mawla, Daniel Harper, L. Pauer, Steven E. Harte, Daniel J. Clauw, Richard E. Harris	2021	18
20	Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia Postgraduate Medicine ·Lesley M. Arnold, Bill McCarberg, Andrew Clair, Ed Whalen, Neal Thomas, Anamaria Jorga, L. Pauer, Richard Vissing, Peter W. Park	2017	17

About L. Pauer

L. Pauer is a scholar working on Psychiatry and Mental health, Pharmacology, Cognitive Neuroscience, Anesthesiology and Pain Medicine and Neurology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), Musculoskeletal pain and rehabilitation (23 papers), Pain Management and Placebo Effect (13 papers), Pain Mechanisms and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Pain Management and Opioid Use (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers). The work is most often cited by research in Psychiatry and Mental health (405 citations), Pharmacology (402 citations), Anesthesiology and Pain Medicine (114 citations), Physiology (407 citations) and Neurology (206 citations). L. Pauer has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joseph C. Arezzo, Julio Rosenstock, Linda LaMoreaux, Daniel J. Clauw, Ed Whalen, Lesley M. Arnold, Richard E. Harris, Vitaly Napadow, Tobias Schmidt‐Wilcke and Johnson P. Hampson. Their work appears in journals such as Journal of Pain, Clinical Journal of Pain, Pain Medicine, European Psychiatry and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact